FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled June 24, 2026

Aripiprazole Tablets USP recall — Ajanta Pharma USA Inc

Hazard: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0594-2026
Brand
Ajanta Pharma USA
Classification
Class II
Units affected
6,143 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Affected products

Companies & origin

Recalling firm location
Bridgewater, NJ, United States
Firm address
400 Crossing Blvd Ste 102, 08807-2863

Identifying details (verbatim from the notice)

Product codes / lots
Lot: PA00805, expires: 01/31/2029
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
99046
Recall initiated
May 27, 2026
FDA classified
June 16, 2026
FDA report date
June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page